132 related articles for article (PubMed ID: 325137)
1. Increased responsiveness to macrophage-activating factor (MAF) after alteration of macrophage membranes.
Piessens WF; Remold HG; David JR
J Immunol; 1977 Jun; 118(6):2078-82. PubMed ID: 325137
[TBL] [Abstract][Full Text] [Related]
2. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
3. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
Postlethwaite AE; Kang AH
J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
[TBL] [Abstract][Full Text] [Related]
4. Chemical treatment of macrophages increases their responsiveness to migration inhibitory factor (MIF).
Remold HG
J Immunol; 1977 Jan; 118(1):1-5. PubMed ID: 187695
[TBL] [Abstract][Full Text] [Related]
5. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
6. Preparation and antitumor effect of macrophage activating factor (MAF) encapsulated in liposomes bearing a monoclonal anti-human melanoma (A375) antibody.
Watanabe Y; Uchida E; Higuchi M; Imai Y; Osawa T
J Biol Response Mod; 1987 Oct; 6(5):556-68. PubMed ID: 3316511
[TBL] [Abstract][Full Text] [Related]
7. Enhanced uptake of 3H-glucosamine by macrophages stimulated by macrophage-activating factor.
Sober AJ; Haynie M; David JR
J Immunol; 1979 May; 122(5):1731-5. PubMed ID: 448106
[TBL] [Abstract][Full Text] [Related]
8. An assay for macrophage activating factor based on the adherence of oil-elicited guinea pig macrophages: characterization of a lymphokine-induced release of hydrogen peroxide from elicited macrophages.
Talmadge KW; Peck R
Lymphokine Res; 1986; 5(1):35-47. PubMed ID: 3511329
[TBL] [Abstract][Full Text] [Related]
9. Possible role of macrophage glycolipids as receptors for migration inhibitory factor (MIF).
Higgins TJ; Sabatino AP; Remold HG; David JR
J Immunol; 1978 Sep; 121(3):880-6. PubMed ID: 357658
[TBL] [Abstract][Full Text] [Related]
10. Role of sialic acid in the macrophage glycolipid receptor for MIF.
Liu DY; Petschek KD; Remold HG; David JR
J Immunol; 1980 Apr; 124(4):2042-7. PubMed ID: 6988512
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
12. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-activating factors from different T cell clones induce distinct macrophage functions.
Gemsa D; Debatin KM; Kramer W; Kubelka C; Deimann W; Kees U; Krammer PH
J Immunol; 1983 Aug; 131(2):833-44. PubMed ID: 6190940
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
Sone S; Fidler IJ
J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
[TBL] [Abstract][Full Text] [Related]
15. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
Taramelli D; Varesio L
J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
[TBL] [Abstract][Full Text] [Related]
16. The production of a macrophage-activating factor from rainbow trout Salmo gairdneri leucocytes.
Graham S; Secombes CJ
Immunology; 1988 Oct; 65(2):293-7. PubMed ID: 3056854
[TBL] [Abstract][Full Text] [Related]
17. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
Sone S; Poste G; Fidler IJ
J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
Thomson AW; Moon DK; Geczy CL; Nelson DS
Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
[TBL] [Abstract][Full Text] [Related]
19. Partial purification of a macrophage-activating factor for glucose consumption (MAF-G) produced by a human T-cell hybridoma and its relation to a growth-promoting factor.
Osada H; Furukawa-Nakanishi K; Miyamoto D; Kobayashi Y; Osawa T
Lymphokine Res; 1989; 8(4):393-405. PubMed ID: 2509820
[TBL] [Abstract][Full Text] [Related]
20. In vitro modulation of macrophage tumoricidal activity: partial characterization of a macrophage-activating factor(s) in supernatants of NaIO4-treated peritoneal cells.
Weinberg JB; Hibbs JB
J Reticuloendothel Soc; 1979 Sep; 26(3):283-93. PubMed ID: 228037
[No Abstract] [Full Text] [Related]
[Next] [New Search]
